Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07142070

Effect of Systemic Retinoic Acid Use on Micro Ribonucleic Acid (mRNA) Expression

Evaluation of the Effect of Systemic Retinoic Acid Use on Micro Ribonucleic Acid (mRNA) Expression in Saliva and Serum

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Medipol University · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Ribonucleic acids (RNA) are molecules that transfer genetic information from the nucleus to the cytoplasm for protein translation. A subgroup of non-coding or non-messenger RNAs, known as microRNAs (miRNAs), regulates the expression of complementary mRNAs without coding for proteins. In this study, the investigators aimed to evaluate the effect of systemically administered oral isotretinoin on gingival health in terms of microRNA (miRNA), a molecule of interest in periodontal research, before, during, and after treatment.

Detailed description

Healthy participants (n:25) enrolled for this study. Samples will be collected for each patient at the following time points: immediately before the initiation of retinoic acid treatment, during treatment at week 5 (T1), during treatment at month 5 (T2), and three months after the end of treatment (T3).

Conditions

Interventions

TypeNameDescription
OTHERSaliva, serum samplingSaliva were collected to analyze the selected markers as unstimulated samples during the early hours of the day. The saliva was centrifuged and then transferred into Eppendorf tubes. Venous puncture was performed after saliva collection and 10 mL of blood samples were collected by qualified staff from each participant (Periopaper, Oraflow Inc., Plainview, NY, USA). Saliva, serum were then stored at -80 °C until analysis.
DRUGoral isotretinoinoral isotretinoin

Timeline

Start date
2025-09-01
Primary completion
2025-12-31
Completion
2026-02-01
First posted
2025-08-26
Last updated
2025-08-26

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07142070. Inclusion in this directory is not an endorsement.